Canada markets closed

Innovent Biologics, Inc. (6IB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.9600-0.0200 (-0.50%)
At close: 03:29PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Depreciation & amortization
385,103
385,103
319,422
204,747
85,627
Stock based compensation
574,197
574,197
469,490
501,572
402,500
Change in working capital
403,389
403,389
309,908
-91,982
-334,056
Inventory
358,945
358,945
-105,388
-643,281
-311,427
Other working capital
-1,235,650
-1,235,650
-3,300,534
-3,872,359
-1,079,466
Other non-cash items
-311,412
-311,412
-61,920
-49,547
-5,343
Net cash provided by operating activites
147,810
147,810
-1,918,804
-2,024,843
-307,688
Cash flows from investing activities
Investments in property, plant and equipment
-1,383,460
-1,383,460
-1,381,730
-1,847,516
-771,778
Purchases of investments
-9,414,467
-9,414,467
-10,325,704
-10,337,888
-11,644,979
Sales/Maturities of investments
9,244,320
9,244,320
10,019,845
10,121,480
7,160,676
Other investing activites
232,359
232,359
144,955
-785,962
-49,844
Net cash used for investing activites
-998,662
-998,662
-1,435,185
-2,698,148
-5,184,588
Net change in cash
1,736,405
1,736,405
-461,907
280,370
-580,155
Cash at beginning of period
1,016,165
1,016,165
1,359,408
1,276,178
2,425,806
Cash at end of period
2,745,693
2,745,693
1,016,165
1,359,408
1,276,178
Free Cash Flow
Operating Cash Flow
147,810
147,810
-1,918,804
-2,024,843
-307,688
Capital Expenditure
-1,383,460
-1,383,460
-1,381,730
-1,847,516
-771,778
Free Cash Flow
-1,235,650
-1,235,650
-3,300,534
-3,872,359
-1,079,466